Jinwei is a biotechnology company dedicated to pursuing innovative technology to discover and develop cures for people with serious and life-threatening diseases. Since the establishment in 2016, Shanghai Jinwei Biotechnology has been leveraging its knowledge in lentiviral-vector-based technology with international partners such as the Pasteur Institute and Huashan Hospital, focusing on delivering safe and efficient therapeutic medicines for patients suffering from cancers and infectious diseases such as Hepatitis B.